Business Description
AXIM Biotechnologies Inc
NAICS : 325412
SIC : 2834
ISIN : US05463V1008
Description
AXIM Biotechnologies Inc is a vertically integrated research and development company focused on improving the landscape for the diagnosis of ophthalmological conditions such as Dry Eye Disease through rapid diagnostic tests. Additionally, The company owns IP and has conducted research on SARS-CoV-2 (COVID-19) rapid neutralizing antibody tests to detect levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells, as well as for oncological indications.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -2.56 | |||||
| Debt-to-Equity | -0.71 | |||||
| Debt-to-EBITDA | -2.32 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -33.1 | |||||
| Beneish M-Score | -2.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 19.7 | |||||
| 3-Year EPS without NRI Growth Rate | 23.9 | |||||
| 3-Year FCF Growth Rate | 45 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.05 | |||||
| 9-Day RSI | 37.42 | |||||
| 14-Day RSI | 39.32 | |||||
| 6-1 Month Momentum % | -68.04 | |||||
| 12-1 Month Momentum % | -88.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Days Inventory | 5110 | |||||
| Days Payable | 638166 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -25.2 | |||||
| Shareholder Yield % | -220.78 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 98.93 | |||||
| Operating Margin % | -2490.32 | |||||
| Net Margin % | -4447.31 | |||||
| FCF Margin % | -819.35 | |||||
| ROA % | -103.01 | |||||
| ROIC % | -28.42 | |||||
| ROC (Joel Greenblatt) % | -1009.93 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -2.18 | |||||
| EV-to-EBITDA | -2.5 | |||||
| EV-to-Revenue | 78.73 | |||||
| EV-to-FCF | -9.61 | |||||
| Earnings Yield (Greenblatt) % | -45.87 | |||||
| FCF Yield % | -156.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AXIM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AXIM Biotechnologies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.093 | ||
| EPS (TTM) ($) | -0.023 | ||
| Beta | -0.61 | ||
| Volatility % | 103.15 | ||
| 14-Day RSI | 39.32 | ||
| 14-Day ATR ($) | 0.000578 | ||
| 20-Day SMA ($) | 0.002115 | ||
| 12-1 Month Momentum % | -88.74 | ||
| 52-Week Range ($) | 0.0013 - 0.0205 | ||
| Shares Outstanding (Mil) | 302.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AXIM Biotechnologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AXIM Biotechnologies Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
AXIM Biotechnologies Inc Frequently Asked Questions
What is AXIM Biotechnologies Inc(AXIM)'s stock price today?
The current price of AXIM is $0.00. The 52 week high of AXIM is $0.02 and 52 week low is $0.00.
When is next earnings date of AXIM Biotechnologies Inc(AXIM)?
The next earnings date of AXIM Biotechnologies Inc(AXIM) is 2025-02-19 Est..
Does AXIM Biotechnologies Inc(AXIM) pay dividends? If so, how much?
AXIM Biotechnologies Inc(AXIM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers